Latest News

We are recruiting! Assay Scientist & Laboratory Assistant

Cellectricon continues to grow and we are now looking to fill two positions; an assay development and screening scientist and a laboratory assistant.

The employments offers exciting opportunities to provide important support to our ongoing customer projects. Learn more about Cellectricon and the two positions on our Careers page.

Read more

Free webinar: Translational in vitro assays for early CNS drug discovery

Thursday October 5 @ 4 pm CEST (10 am EDT)

Join our webinar to learn about:

  • Cellectricon’s technology platform for phenotypic screening in CNS drug discovery.
  • Development of functional assays for screening of small molecule- and siRNA libraries with improved translation to the clinic.
  • Combining and coupling functional and morphological readouts.

Speaker:
Paul Karila, VP of Discovery Services, Cellectricon

Click here to register and learn more about the webinar.

Read more

Luncheon seminar: A humanized screening platform for chronic pain

Friday June 16 2017 at 12-13.30 pm CET
@ Cellectricon head office Mölndal, Sweden

Join our free seminar to learn about:

  • Cellectricon’s unique technology platform and discovery services.
  • Phenotypic screening approaches in pain research and how iPSC-derived neurons can be used in drug discovery.
  • Principles of our humanized phenotypic screening platform and how it can be applied for stem cell-based screening against disease-relevant phenotypes.

Click here to register and learn more about the luncheon seminar.

Read more

Free webinar: A humanized phenotypic screening platform for chronic pain

Thursday March 9th @ 4 pm CET (10 am EST)

Don’t miss our upcoming webinar on stem cell-based pain and CNS drug discovery. Attendees can gain knowledge of compound profiling to advance research in the CNS and pain therapeutic fields and get an understanding of the principles of operation of Cellectricon’s phenotypic screening platform.

Speakers:
Paul Karila, VP of Discovery Services, Cellectricon
Ashley Barnes, Head of Drug Discovery Services, Censo Biotechnologies

Click here to register and learn more about the webinar.

Read more

Cellectricon and Censo Biotechnologies introduce a joint technology access program utilizing high-quality Human iPSC-based discovery services for CNS and pain research

Mölndal, Sweden and Cambridge, UK – 26th January 2017

Cellectricon AB and Censo Biotechnologies Ltd are announcing the introduction of a joint technology access program for a fully humanized phenotypic screening platform targeting preclinical neuroscience and chronic pain research.

Read more
  • Page 1 of 14
  • >